Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

131.37 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Congressional Trading Report: Rep. Thomas Kean Bought Over $1K In Abbott Laboratories Stock
 
Via Benzinga
US Stock Futures Trade Mixed After Skirting Record Highs In Last Session: GE Aerospace, American Airlines, Union Pacific In Focus
U.S. stock futures were mixed on Thursday following Wednesday's rally. Futures of benchmark indices were lower except Dow Jones. 
Via Benzinga
Topics Stocks
My Top 5 Stocks to Buy in Early 2025
Via The Motley Fool
S&P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In 'Fear' Zone
 
Via Benzinga
Topics Stocks
How Is The Market Feeling About Abbott Laboratories?
 
Via Benzinga
S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run
Market surges on AI Stargate initiative & strong earnings. S&P 500 hits record high of 6,100 points, led by tech giants & semiconductor stocks. 
Via Benzinga
Topics Artificial Intelligence Government Stocks
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
 
Via Benzinga
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript
ABT earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall
Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong performance in medical devices. 
Via Benzinga
Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What's Driving Markets Wednesday?
Tech stocks enjoyed a surge Wednesday, driven by a sharp rise in semiconductor shares after President Donald Trump, OpenAI's Sam Altman, Oracle Corp. 
Via Benzinga
Topics Artificial Intelligence Government
Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit
The company expects to earn an adjusted $5.05 to $5.25 per share this year, in line with forecasts for $5.16. 
Via Investor's Business Daily
US Stocks Likely To Open Higher As President Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch
U.S. stocks could open on a positive note on Wednesday, continuing to rally after Donald Trump's inauguration as the 47th President of the U.S. on Monday. 
Via Benzinga
Topics Artificial Intelligence Government
Earnings Scheduled For January 22, 2025
 
Via Benzinga
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
The CNN Business Fear & Greed Index measures market sentiment, with higher fear putting pressure on stocks. 
Via Benzinga
Topics Government Stocks
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday
 
Via Benzinga
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
Via The Motley Fool
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
The U.S. Food and Drug Administration announced a ban on Red No. 3, an artificial food coloring linked to cancer in animal studies, effective Jan. 15, 2027. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees
Via The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR by 2030. 
Via Benzinga
2 No-Brainer Dividend Stocks to Buy With $250 in 2025
Via The Motley Fool
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Via The Motley Fool
3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years
Via The Motley Fool
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
Via The Motley Fool
10 Dividend Stocks For Intergenerational Wealth
The Dividend Aristocrats broadly have durable competitive advantages, and long-term growth. 
Via Talk Markets
Topics Stocks / Equities
Introducing the "Dividend Seven" Stocks
Via The Motley Fool
My Top 10 Stocks to Buy for 2025
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.